As well as forming the cornerstone of the “amyloid hypothesis” of AD 22 in demonstrating that mutations in the APP gene or its overexpression, directly or indirectly, both drive the formation of NFTs, these studies in FAD and DS patients also point to a link between amyloidogenesis and α‐synuclein aggregation 35. This evidence concerns the gene APP and familial Alzheimer disease.